Organization: Health Canada
Year: 2023
Month: September
Request Number: A-2023-000155
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of the Gilead Sciences facility (Site A) on Mississauga Rd.
Disposition: Disclosed in part
Number of pages: 47